MedPAC Recommends Methods To Ease Transition To Competitive Bidding
This article was originally published in The Gray Sheet
Executive Summary
Inclusion of a mandatory trial period in a competitive bidding program that allows Medicare beneficiaries to switch to a non-winning supplier if dissatisfied with the program's quality may be a way to gain beneficiary support for competitive bidding, according to MedPAC's 1June report
You may also be interested in...
Lab Industry Ramping Up Heart, Diabetes Tests Covered Under Rx Bill
Increased lab test use likely will occur under a provision in the Medicare reform bill covering an initial preventive physical exam for beneficiaries, according to MCF Compliance President Charles Root
Lab Industry Ramping Up Heart, Diabetes Tests Covered Under Rx Bill
Increased lab test use likely will occur under a provision in the Medicare reform bill covering an initial preventive physical exam for beneficiaries, according to MCF Compliance President Charles Root
Lab concerns with Medicare legislation
Provision in Senate version requiring a 20% co-pay on diagnostics for Medicare patients would "put a lot of pressure on laboratories," Dade Behring's Louise Pearson, VP and general counsel, maintained July 22 at AACC's annual meeting in Philadelphia. "The 20% co-pay would average about $2.30, and the actual cost of billing that out is around $15," she noted. Labs also are opposed to a provision in the House version that would implement competitive bidding for lab tests (1"The Gray Sheet" June 23, 2003, p. 12)...